Zobrazeno 1 - 10
of 44
pro vyhledávání: '"B. Pegaz"'
Publikováno v:
Photochemistry and Photobiology. 85:1400-1408
Combining photodynamic therapy (PDT) using verteporfin (Visudyne(R)) with ranibizumab (Lucentis(R)) can optimize the overall treatment outcome by providing more efficacy in vessel closure, and thus reduce the need for retreatment in patients with wet
Publikováno v:
Angiogenesis
Angiogenesis, Vol. 11, No 3 (2008) pp. 235-43
Angiogenesis, Vol. 11, No 3 (2008) pp. 235-43
The aim of the present study was to monitor photodynamic angioocclusion with verteporfin in capillaries. Details of this process were recorded under a microscope in real-time using a high-sensitivity video camera. A procedure was developed based on i
Publikováno v:
Journal of Photochemistry and Photobiology B: Biology. 85:216-222
Particle size should be optimized to achieve targeted and extended drug delivery to the affected tissues. We describe here the effects of the mean particle size on the pharmacokinetics and photothrombic activity of meso-tetra(carboxyphenyl)porphyrin
Autor:
T. Papo, Jean-Pierre Laissy, C. Antoine, B. Pegaz-Fiornet, C. Bauer, Marie-Paule Chauveheid, M.C. Dombret, O. Lidove, C. Lamotte, C. Legendre, T. Petit, B. Crestani, D. Lieberherr
Publikováno v:
La Revue de Médecine Interne. 27:248-252
Resume Introduction. – Le sirolimus est un nouvel immunosuppresseur utilise surtout en transplantation renale. Dans le futur, il pourrait remplacer les anticalcineurines telle la ciclosporine. Ce medicament donne des effets secondaires dont les plu
Autor:
Hubert van den Bergh, Jean-Pierre Ballini, Elodie Debefve, Yvette Niamien Kouakou-Konan, B. Pegaz, Francois Borle
Publikováno v:
Journal of Photochemistry and Photobiology B: Biology. 80:19-27
In the present work, we performed a preclinical inter-comparison study using several photosensitizers with the goal of optimizing photodynamic therapy (PDT) for the treatment of choroidal neovascularization (CNV) associated with age-related macular d
Autor:
B. Pegaz, Jean-Pierre Ballini, Elodie Debefve, Yvette Konan-Kouakou, Hubert van den Bergh, Florence Delie, Norbert Lange, Angelica Vargas, Robert Gurny
Publikováno v:
International Journal of Pharmaceutics, Vol. 286, No 1-2 (2004) pp. 131-145
Hydrophobic porphyrins are potentially interesting molecules for the photodynamic therapy (PDT) of solid cancers or ocular vascularization diseases. Their pharmaceutical development is, however, hampered by their lipophilicity, which renders formulat
Autor:
C, Bauer, O, Lidove, C, Lamotte, T, Petit, D, Lieberherr, M P, Chauveheid, C, Legendre, B, Crestani, M C, Dombret, J P, Laissy, C, Antoine, B, Pegaz-Fiornet, T, Papo
Publikováno v:
La Revue de medecine interne. 27(3)
Sirolimus is a new immunosuppressive drug used in organ transplantation, particularly in renal transplantation. In the future, it could replace calcineurin inhibitors such as cyclosporine. It is currently associated with side effects, such as thrombo
Autor:
B. Pegaz, S. Spaniol, Jean-Pierre Ballini, Elodie Debefve, V. Albrecht, H. van den Bergh, N. E. Nifantiev, D.V. Scheglmann, Yvette Konan-Kouakou, Georges Wagnières
Publikováno v:
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 28(1-2)
The objective of this study was to evaluate the ability of meso-tetra(hydroxyphenyl)chlorin (m-THPC) encapsulated into liposomal formulations to occlude neovascularization. Two m-THPC formulations including conventional or plain liposomes (Foslip) ba
Publikováno v:
Journal des maladies vasculaires. 24(3)
We report a case of Behçet's disease complicated with a popliteal aneurysm, which appeared 8 years after first etiologic diagnosis. The points of interest of this observation are the pre-operative explorations and particularly the Magnetic Resonance
Autor:
Volker Albrecht, Y. N. Konan, Francois Borle, Jean-Pierre Ballini, Elodie Debefve, G. Wagnieres, S. Spaniol, H. van den Bergh, N. E. Nifantiev, B. Pegaz, D.V. Scheglmann
Publikováno v:
Photochemistry and Photobiology. 81:1505
In the present study, photodynamic activity of a novel photosensitizer (PS), Chlorin e(6)-2.5 N-methyl-d-glucamine (BLC 1010), was evaluated using the chorioallantoic membrane (CAM) as an in vivo model. After intravenous (i.v.) injection of BLC 1010